Abterra Bio Has Moved To Sorrento Valley
In 2009, Abterra Bio began as Digital Proteomics LLC, a spin-out of the University of California – San Diego. Founders Pavel Pevzner and Vineet Bafna, as well as Natalie Castellana, Stefano Bonissone, and Anand Patel have been a part of Abterra’s story since its inception.
Our employees fine-tuned the technology for antibody sequencing and discovery, and as we started to hire more people, we outgrew our first location: a shared lab bench in a biotech start-up incubator. In 2020 with 6 employees, we moved to the San Diego Science Center, our first real office and lab that we could call our own. We invested in a Thermo Fisher Orbitrap Eclipse mass spectrometer to expand our throughput and add capabilities to our services to customers looking for antibody discovery, sequencing, and repertoire analysis. Throughout our time there, we continued to grow (See the Abterra team now), and eventually traded that office for yet another larger one.
Our current chapter has begun in our new Sorrento Valley office and we couldn’t be more excited. We’re enjoying our state-of-the-art lab, multiple floors of offices, and even a conference room! At first we wondered, “Is this too much?” but after some reflection, realized how hard we have worked to get here. We’ve already begun filling the lab with new equipment, including a new sequencer that quadruples our NGS sequencing throughput. Our new space provides the room to grow our team and our capabilities for our valued customers.
If you’re considering a project with us, we’d love to talk to you.
Related Posts
VHH Antibody Repertoire to Phage Library Comparison
Project Summary Camelids such as llamas and alpacas produce conventional antibodies as well as heavy-chain only antibodies (HCAbs) from which the small, stable antigen-binding domain (VHH) can be extracted. Abterra Biosciences developed Reptor, a proprietary antibody...
Case Study: Reptor Biological vs Technical Replicates
Project Summary Next-generation sequencing of B cell populations (Rep-Seq) has become a powerful tool in immunology and antibody discovery. At Abterra Bio we developed Reptor, an integrated Rep-Seq sequencing and analysis service. A key goal of Reptor is to provide...
Abterra Biosciences is a unique CRO offering antibody sequencing and discovery services. We bring sophisticated algorithmic and machine learning approaches to enable accurate antibody sequencing and functional antibody discovery.
Tell Us About Your Project
Follow Abterra Bio On Social Media
More From Our Blog
VHH Antibody Repertoire to Phage Library Comparison
Project Summary Camelids such as llamas and alpacas produce conventional antibodies as well as...
Case Study: Reptor Biological vs Technical Replicates
Project Summary Next-generation sequencing of B cell populations (Rep-Seq) has become a powerful...
Abterra Opens Its Doors To Celebrate New Location With Open House
Celebrating milestones is an important part of our personal and professional journeys. We wanted...